Quarterly report pursuant to Section 13 or 15(d)

Variable Interest Entities (Tables)

v3.23.1
Variable Interest Entities (Tables)
3 Months Ended
Mar. 31, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Variable Interest Entities
As of March 31, 2023
As of December 31, 2022
(in thousands) $ $
Total assets 128,196  137,675 
Total liabilities 231,374  228,283 

For the Three Months Ended March 31, 2023
For the Three Months Ended March 31, 2022
(in thousands) $ $
Total revenues 130,761  127,138 
Operating expenses:
Claims expense (127,680) (118,985)
Clinical care delivery expense (7,932) (8,912)
Sales, general and administrative expenses (8,668) (14,352)
Depreciation and amortization expenses —  (659)
Premium deficiency reserve income 4,484  14,028